🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Selling, General & Admin
30.5724.627.768.49
Research & Development
156.69121.273.1156.29
Operating Expenses
187.26145.8280.8664.77
Operating Income
-187.26-145.82-80.86-64.77
Interest & Investment Income
15.1811.346.380.07
Other Non Operating Income (Expenses)
0.550.430.21-
Pretax Income
-171.53-134.04-74.28-64.7
Net Income
-171.53-134.04-74.28-64.7
Net Income to Common
-171.53-134.04-74.28-64.7
Net Income Growth
----
Shares Outstanding (Basic)
803100
Shares Outstanding (Diluted)
803100
Shares Change
628.00%241276.23%-89.66%-
EPS (Basic)
-2.14-4.30-5756.41-518.73
EPS (Diluted)
-2.14-4.30-5756.41-518.73
EPS Growth
----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-151.03-114.5-55.08-52.49
Free Cash Flow Per Share
-1.88-3.68-4268.47-420.87
EBITDA
-186.95-145.54-80.66-64.68
D&A For EBITDA
0.310.280.210.09
EBIT
-187.26-145.82-80.86-64.77